BrainSpec
AI-powered brain diagnostics via MR spectroscopy
Boston, United States · Founded 2017
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- brainspecmed.com
- Last Round
- SeedNov 2023
- Rounds
- 3
About
BrainSpec is a health-tech company that develops AI-powered MR spectroscopy analysis software for accurate, non-invasive diagnosis of brain disorders. Its FDA-cleared BrainSpec Core platform assists clinicians in evaluating neurological conditions including Alzheimer's disease using chemical concentration data from standard MRI scanners.
Summary
BrainSpec is a Healthcare company based in Boston, United States, founded in 2017. Its most recent funding was a Seed round in Nov 2023. Investors include Tuesday Capital, Techstars and DCVC (Data Collab).
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Hyland provides content services and intelligent automation solutions for enterprises.
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...